首页> 外国专利> Determination of the presence of an antigen, particularly HLA-B27 antigen, at the surface of a cell, particularly lymphocytes, by cytotoxicity test combined with fluorescent staining

Determination of the presence of an antigen, particularly HLA-B27 antigen, at the surface of a cell, particularly lymphocytes, by cytotoxicity test combined with fluorescent staining

机译:通过细胞毒性试验与荧光染色相结合的方法确定抗原,特别是HLA-B27抗原在细胞,特别是淋巴细胞表面的存在

摘要

The present invention relates to a method of determining the presence of an antigen, particularly the HLA-B.sub.27 antigen, at the surface of cells, particularly lymphocytes, by combining the sensitivity of a cytotoxicity test, particularly a lymphotoxicity test, combined to a fluororescence detection, particularly, by using propidium iodide. The claimed method does not involve any purification of lymphocytes from a blood sample. The erythrocytes contained in the test blood sample are lysed after the immune reaction and complement action is completed. Moreover, the formation of the immune complexes, the complement fixation and reaction and the staining of the cells may take place at the same time in the test tube. This method is therefore very simple and very fast to execute. The facility of reading the positive cells is also an advantage to the claimed method over and above the methods using dyes like eosin or trypan blue, because of the direct visualization of colored cells as positive cells. Another advantage of the claimed method resides in its versatility of reading. Quantitation and identification of the positive cells is rendered feasible by fluorescence microscopy as well as by flow cytofluorometry. The claimed method has been validated in the diagnosis of ankylosing spondylitis (AS) and reactive arthritis (RA) by typing lymphocytes HLA-B.sub.27.
机译:本发明涉及一种通过结合细胞毒性试验,特别是淋巴毒性试验的敏感性来确定在细胞,特别是淋巴细胞表面上抗原特别是HLA-B.sub.27抗原的存在的方法。荧光检测,特别是使用碘化丙啶。所要求保护的方法不涉及从血液样品中纯化任何淋巴细胞。免疫反应结束后,被检血样中的红细胞被溶解,补体作用完成。此外,免疫复合物的形成,补体的固定和反应以及细胞的染色可在试管中同时进行。因此,该方法非常简单且执行速度非常快。与使用诸如曙红或锥虫蓝之类的染料的方法相比,读取阳性细胞的设施也是所要求保护的方法的优点,因为直接将有色细胞可视化为阳性细胞。所要求保护的方法的另一个优点在于其阅读的通用性。通过荧光显微镜以及流式细胞术可以对阳性细胞进行定量和鉴定。通过键入淋巴细胞HLA-B.sub.27,所要求保护的方法已在强直性脊柱炎(AS)和反应性关节炎(RA)的诊断中得到验证。

著录项

  • 公开/公告号US5633132A

    专利类型

  • 公开/公告日1997-05-27

    原文格式PDF

  • 申请/专利权人 IMMUNOVA LTEE;

    申请/专利号US19940234394

  • 发明设计人 RAYNALD ROY;JACQUES HEBERT;

    申请日1994-04-28

  • 分类号G01N33/554;

  • 国家 US

  • 入库时间 2022-08-22 03:10:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号